Author Question: Which child is most likely to retain the benefits of watching prosocial television programming? ... (Read 105 times)

iveyjurea

  • Hero Member
  • *****
  • Posts: 555
Which child is most likely to retain the benefits of watching prosocial television programming?
 
  a. Ruth, who watches many hours of television by herself, but all of it is prosocial
  b. Jael, who watches lots of television, some of it prosocial, with his parents
  c. Riley, who watches a bit of prosocial programming and then acts it out with his mom
  d. Alec, who watches a lot of prosocial programming while his dad watches with him

Question 2

Attention span of older children and teenagers improves because of increased myelinization of the brain's
 
  a. thalamus.
  b. cerebellum.
  c. cerebral cortex.
  d. reticular formation.



meganlapinski

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

C

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library